Tolerance Induction Using Autologous Regulatory T Cell Infusion and Zortress (Everolimus) in Renal Transplant Recipients: a pilot study

Grants and Contracts Details

StatusActive
Effective start/end date2/28/171/25/23

Funding

  • Novartis (domestic): $101,726.00